Subject Well Inc.

SubjectWell drives sponsors, CROs, sites, and site networks to disrupt patient recruitment and commercial development. With the most comprehensive and patient-centric technology platform driven by a growing Patient Network of 13 million+ patients, clinically trained, multilingual patient and site companions, recruiting capabilities across 102 countries, the most extensive digital media network, and services proven to reduce site burden, SubjectWell offers solutions to the greatest challenges in patient recruitment and commercial development.

Accelerate patient enrollment in clinical trials with Trials24/SubjectWell, facilitating access to life-changing medications. We support biopharmaceutical companies and CROs in completing their clinical trials on time, bringing innovative drugs to patients faster.